open access

Vol 5, No 2 (2002)
Original articles
Published online: 2002-06-07
Submitted: 2012-01-23
Get Citation

Estimation of usefulness of monitoring tissue polypeptide antigen - TPA-M concentrations in the effectiveness surgical treatment of urinary bladder cancer

Aleksandra Kochańska-Dziurowicz, Michał J. Mielniczuk, Aleksandra Bijak, Ryszard Palugniok
Nucl. Med. Rev 2002;5(2):109-111.

open access

Vol 5, No 2 (2002)
Original articles
Published online: 2002-06-07
Submitted: 2012-01-23

Abstract

BACKGROUND: Of all cancer tumours, urinary bladder cancer is the fourth must common in men and the seventh in women. The aim of this work was to answer the question whether tissue polypeptide antigen (TPA-M) determination in patients after electroresection of urinary bladder cancer can be used to establish the probability of tumour recurrence.
MATERIAL AND METHODS: The research included 98 patients, all of whom had undertaken electroresection of urinary bladder tumour (TURT), which enabled its removal, and then estimation of malignancy and progression stage according to the international TNM scale. The mean age was 62.7 years. All patients had blood samples taken to determine TPA-M and then underwent routine cystoscopy examination.
RESULTS: The patients with tumour recurrence (60, mean age 64 ± 10) had TPA 30.2 ± 4.3 U/l, the patients without recurrence (38, mean age 61.3 ± 11) had TPA-M 26.2 ± 3.18 U/l (p > 0.1). Taking the TPA-M threshold point 85 U/l as normal, true-positive results were 16.3%, true-negative were 31.6%, falsepositive results were 7.1% and false-negative were 44.9%. The ROC curves with the calculated area under them are the measurement of the diagnostic estimation of TPA-M concentrations in specificity and sensitivity categories.
CONCLUSIONS: For the examined group the calculated P was 0.45. If P value is under 0.5 it is considered that the test should not be used in diagnosing recurrence of urinary bladder cancer.

Abstract

BACKGROUND: Of all cancer tumours, urinary bladder cancer is the fourth must common in men and the seventh in women. The aim of this work was to answer the question whether tissue polypeptide antigen (TPA-M) determination in patients after electroresection of urinary bladder cancer can be used to establish the probability of tumour recurrence.
MATERIAL AND METHODS: The research included 98 patients, all of whom had undertaken electroresection of urinary bladder tumour (TURT), which enabled its removal, and then estimation of malignancy and progression stage according to the international TNM scale. The mean age was 62.7 years. All patients had blood samples taken to determine TPA-M and then underwent routine cystoscopy examination.
RESULTS: The patients with tumour recurrence (60, mean age 64 ± 10) had TPA 30.2 ± 4.3 U/l, the patients without recurrence (38, mean age 61.3 ± 11) had TPA-M 26.2 ± 3.18 U/l (p > 0.1). Taking the TPA-M threshold point 85 U/l as normal, true-positive results were 16.3%, true-negative were 31.6%, falsepositive results were 7.1% and false-negative were 44.9%. The ROC curves with the calculated area under them are the measurement of the diagnostic estimation of TPA-M concentrations in specificity and sensitivity categories.
CONCLUSIONS: For the examined group the calculated P was 0.45. If P value is under 0.5 it is considered that the test should not be used in diagnosing recurrence of urinary bladder cancer.
Get Citation

Keywords

TPA-M; monitoring; urinary bladder cancer

About this article
Title

Estimation of usefulness of monitoring tissue polypeptide antigen - TPA-M concentrations in the effectiveness surgical treatment of urinary bladder cancer

Journal

Nuclear Medicine Review

Issue

Vol 5, No 2 (2002)

Pages

109-111

Published online

2002-06-07

Bibliographic record

Nucl. Med. Rev 2002;5(2):109-111.

Keywords

TPA-M
monitoring
urinary bladder cancer

Authors

Aleksandra Kochańska-Dziurowicz
Michał J. Mielniczuk
Aleksandra Bijak
Ryszard Palugniok

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl